Overview
Semax is a synthetic heptapeptide derived from the ACTH(4-10) sequence and extended with a Pro-Gly-Pro motif. The pre-filled research pen contains 20mg total, divided into four 5mg portions, providing a standardized format for laboratory studies of peptide stability and neuropeptide-related signaling.
Research Reference: View compound profile on NIH PubChem
Research Focus
WHAT THIS FORMULA FEATURES
The Met-Glu-His-Phe-Pro-Gly-Pro sequence combines an ACTH-derived core with a Pro-Gly-Pro extension that is commonly discussed in peptide research for its effect on resistance to enzymatic degradation.
EXPECTED RESEARCH READOUTS
Potential research endpoints include peptide-degradation and stability assays, transcriptional-response profiling, neurotrophin-related markers, cell-stress and viability measurements, and other neuropeptide-signaling readouts in appropriate in-vitro or experimental models.
Key Characteristics
PRODUCT CONFIGURATION
Total dosage: 20mg
Package: 1 pre-filled research pen
Configuration: 4 × 5mg
Pen color: Red
RESEARCH PROFILE
Compound profile: ACTH(4-10)-derived heptapeptide research compound
Format: Pre-filled research pen
Fulfilment: Fast Stock across local locations + Global shipping
Transit: Cold-chain packed with ice packs
Research use only. Not approved for human or animal use.
